Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 17, 2024 -- Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 10 in BMJ Open Diabetes Research & Care.
Chan Soon Park, from Seoul National University Hospital in South Korea, and colleagues used data from 8,794 patients with T2DM participating in the U.K. Biobank (2006 to 2010 with follow-up through 2021) to understand the prognostic value of personality (sociability, warmth, diligence, curiosity, and nervousness) and its association with lifestyle factors.
The researchers found that during a median of 13.6 years of follow-up, diligence was significantly associated with a reduced risk for incident CVD. A trend toward lower incidence was seen for the composite outcome (adjusted hazard ratio, 0.93), as well as individual components: myocardial infarction, ischemic stroke, atrial fibrillation, and heart failure. For both high and low diligence, healthy lifestyle behaviors significantly reduced the risk for composite CVDs in groups. A structural equation model showed that diligence directly affected the risk for the primary outcome or indirectly by modifying lifestyle behaviors.
"These findings highlight the importance of assessing personality traits for cardiovascular risk prediction and modifying lifestyle factors as preventive strategies for patients with T2DM," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
32 Percent of U.S. Adults Consumed Fast Food on a Given Day in 2021 to 2023
FRIDAY, June 27, 2025 -- Over 30 percent of adults and children consumed fast food on a given day during August 2021 to August 2023, according to two reports from the National...
Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access...
ADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 Diabetes
FRIDAY, June 27, 2025 -- Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated hemoglobin (HbA1c) among...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.